The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
12
Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.EBI
Lund University
35
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.EBI
The Hashemite University
13
Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells.EBI
Lund University
3
Synthesis and galectin-binding activities of mercaptododecyl glycosides containing a terminalß-galactosyl group.EBI
National Institute of Advanced Industrial Science and Technology (Aist)
22
Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domain.EBI
Lund University
9
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer.EBI
Galecto Biotech AB
9
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket.EBI
Lund University
17
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer.EBI
Galecto Biotech AB
39
Discovery of EBI
Peking Union Medical College
15
Discovery of Selective and Orally Available Galectin-1 Inhibitors.EBI
Galecto Biotech
7
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.EBI
Griffith University
11
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.EBI
Galecto Biotech
29
Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.EBI
Lund University
11
Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain.EBI
Lund University
10
Rational Design and Synthesis of Methyl-β-d-galactomalonyl Phenyl Esters as Potent Galectin-8EBI
Griffith University
5
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.EBI
Institute of Science Education and Research-Kolkata (Iiser) Kolkata
24
Epimers Switch Galectin-9 Domain Selectivity: 3EBI
Lund University
35
Pyrazolo[1,5-A]PYRAZIN-4-YL derivativesBDB
Pfizer